Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33$65.0 million; XPHOZAH generated net sales revenue of $25.0 million Company ends Q2 with$238.5 million in cash, cash equivalents and investments Company raises 2025 IBSRELA net sales revenue expectations to $250-$260 million Conference call scheduled for 4:30 PM Eastern Time WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) - ...